Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director | April 26, 2019 | April 30, 2019 |
| Bank of New York Mellon CorpBK · Entity 2899 | Director | February 11, 2022 | February 15, 2022 |
| GCM Grosvenor Inc.GCMG · Entity 2006 | Director | September 30, 2026 | October 02, 2026 |
| Motorola Solutions, Inc.MSI · Entity 2943 | Director | May 14, 2018 | May 16, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 26, 2019 · Filed April 30, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 40,053 |
Reported balance
After 2019-04-26 transaction · row 1
1 source rowRow 1 · 2019-04-26 · Grant · Acquired 2,241 · Balance 40,053 F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $78.06 · Expires 2029-04-25 | Direct | 10,146 |
Reported balance
After 2019-04-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-26 · Grant · Acquired 10,146 · Balance 10,146 F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Bank of New York Mellon Corp
Report date February 11, 2022 · Filed February 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,710.965 |
Reported balance
After 2022-02-11 transaction · row 1
1 source rowRow 1 · 2022-02-11 · Grant · Acquired 100.097 · Balance 21,710.965 F1: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.
GCM Grosvenor Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 129,575 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 5,722 · Balance 129,575 F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Class A Common Stock of the Issuer. F2: This award of RSUs was granted pursuant to the Issuer's Amended and Restated 2020 Incentive Award Plan, in lieu of quarterly cash compensation at the election of the Reporting Person, and is fully vested as of the date of grant. Shares of Class A Common Stock in settlement of vested RSUs will be delivered upon the earliest to occur of the Reporting Person's "separation from service" from the Issuer, a "change in control event" of the Issuer or the Reporting Person's death or disability. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Class A Common Stock of the Issuer.
F2: This award of RSUs was granted pursuant to the Issuer's Amended and Restated 2020 Incentive Award Plan, in lieu of quarterly cash compensation at the election of the Reporting Person, and is fully vested as of the date of grant. Shares of Class A Common Stock in settlement of vested RSUs will be delivered upon the earliest to occur of the Reporting Person's "separation from service" from the Issuer, a "change in control event" of the Issuer or the Reporting Person's death or disability.
Motorola Solutions, Inc.
Report date May 14, 2018 · Filed May 16, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Motorola Solutions, Inc. - Common StockSEC Table I · non-derivative | Direct | 43,804.8474 |
Reported balance
After 2018-05-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-14 · Grant · Acquired 1,770 · Balance 43,804.8474 F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended. F2: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock. |
| Motorola Solutions, Inc. - Common StockSEC Table I · non-derivative | IndirectBy Trust | 640 |
Reported balance
Holding disclosure · report date 2018-05-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 640 F3: Samuel C. Scott III is the trustee of a Money Purchase Pension Plan Trust for Samuel C. Scott III. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended.
F2: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock.
F3: Samuel C. Scott III is the trustee of a Money Purchase Pension Plan Trust for Samuel C. Scott III.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2017 Filed Aug 15, 2017 20:34 UTC | Bank of New York Mellon Corp BK · Entity 2899 | GrantCommon Stock | 75.804 | $49.74 | $3,770.64 |
DisclosureSEC source: 0001209191-17-048981 · doc4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,748.783 F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:33 UTC | Motorola Solutions, Inc. MSI · Entity 2943 | GrantMotorola Solutions, Inc. - Common Stock | 2,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001578512-17-000011 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,218.099 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended. F2 · balance_after: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock. Read SEC document |
| May 12, 2017 Filed May 16, 2017 20:46 UTC | Bank of New York Mellon Corp BK · Entity 2899 | GrantCommon Stock | 67.198 | $44.23 | $2,972.30 |
DisclosureSEC source: 0001209191-17-032717 · doc4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,672.979 F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 18,148 | $0.00 Strike: $43.64 | $0.00 |
DisclosureSEC source: 0001179110-17-006411 · edgar.xml · derivative · entry 2 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,148 Underlying: Common shares · 18,148 shares Expires 2027-04-27 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006411 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,867 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 21, 2017 Filed Apr 25, 2017 20:39 UTC | Bank of New York Mellon Corp BK · Entity 2899 | GrantDeferred Stock Units · Derivative | 2,780 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-028130 · doc4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,010.8722 Underlying: Common Stock · 2,780 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1. F3 · price: N/A. F2 · derivative.exercise_date: The deferred stock units vest on the earlier of the date of the Corporation's 2018 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning of the 30th day following grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvested in additional deferred stock units. F2 · derivative.expiration_date: The deferred stock units vest on the earlier of the date of the Corporation's 2018 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning of the 30th day following grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvested in additional deferred stock units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:44 UTC | Bank of New York Mellon Corp BK · Entity 2899 | GrantCommon Stock | 68.362 | $43.29 | $2,959.33 |
DisclosureSEC source: 0001209191-17-010613 · doc4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,605.781 F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 22:48 UTC | Bank of New York Mellon Corp BK · Entity 2899 | GrantCommon Stock | 66.576 | $44.26 | $2,946.69 |
DisclosureSEC source: 0001209191-16-149845 · doc4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,537.419 F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. Read SEC document |
| April 29, 2016 Filed May 3, 2016 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-023682 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,430 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 24, 2015 Filed Apr 28, 2015 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-006746 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,631 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-007327 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,838 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-007410 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,303 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007447 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,206 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 29, 2011 Filed May 3, 2011 21:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-007236 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,387 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 23, 2010 Filed Apr 27, 2010 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-007458 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,220 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 22:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 555 | $53.99 Strike: $0.00 | $29,964.45 |
DisclosureSEC source: 0001179110-10-000404 · edgar.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,602 Underlying: Common shares · 555 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 20:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 606 | $49.47 Strike: $0.00 | $29,978.82 |
DisclosureSEC source: 0001179110-09-014053 · edgar.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,009 Underlying: Common Shares · 606 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 21:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 605 | $47.04 Strike: $0.00 | $28,459.20 |
DisclosureSEC source: 0001179110-09-010343 · edgar.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,363 Underlying: Common Shares · 605 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 24, 2009 Filed Apr 28, 2009 22:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-026812 · a4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,112 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2009 Filed Apr 2, 2009 23:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 534 | $47.70 Strike: $0.00 | $25,471.80 |
DisclosureSEC source: 0001104659-09-022381 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,723 Underlying: Common Shares · 534 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2008 Filed Jan 5, 2009 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 477 | $53.37 Strike: $0.00 | $25,457.49 |
DisclosureSEC source: 0001104659-09-000351 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Shares · 477 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2008 Filed Oct 2, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 442 | $57.58 Strike: $0.00 | $25,450.36 |
DisclosureSEC source: 0001104659-08-061721 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672 Underlying: Common Shares · 442 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2008 Filed Jul 2, 2008 23:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 481 | $52.97 Strike: $0.00 | $25,478.57 |
DisclosureSEC source: 0001104659-08-043860 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,216 Underlying: Common Shares · 481 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 25, 2008 Filed Apr 30, 2008 00:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-028079 · a4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,647 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2008 Filed Apr 2, 2008 22:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 462 | $55.15 Strike: $0.00 | $25,479.30 |
DisclosureSEC source: 0001104659-08-022157 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,723 Underlying: Common Shares · 462 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2007 Filed Jan 2, 2008 23:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 454 | $56.15 Strike: $0.00 | $25,492.10 |
DisclosureSEC source: 0001104659-08-000233 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 Underlying: common shares · 454 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2007 Filed Oct 3, 2007 00:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 475 | $53.62 Strike: $0.00 | $25,469.50 |
DisclosureSEC source: 0001104659-07-072702 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795 Underlying: common shares · 475 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock equivalent units · Derivative | 317 | $53.55 Strike: $0.00 | $16,975.35 |
DisclosureSEC source: 0001104659-07-052113 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 Underlying: common shares · 317 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| May 30, 2007 Filed May 31, 2007 19:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | PurchaseCommon shares without par value | 6,000 | $56.26 | $337,560.00 |
DisclosureSEC source: 0001104659-07-044338 · a4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,730 Read SEC document |
| April 27, 2007 Filed May 1, 2007 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-034480 · a4.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,730 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.